Page last updated: 2024-08-16

ribavirin and Anemia, Splenic

ribavirin has been researched along with Anemia, Splenic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, TW; Chu, HC; Fan, HL; Hsieh, CB; Hsieh, TY; Hsu, KF1
Abe, H; Aizawa, Y; Atsukawa, M; Fukuda, T; Itokawa, N; Iwakiri, K; Kawamoto, C; Kondo, C; Matsushita, Y; Nakagawa, A; Nakatsuka, K; Sakamoto, C; Shimada, N; Tsubota, A1
Akahoshi, T; Ikejiri, K; Korenaga, D; Saku, M; Takenaka, K; Tomikawa, M1
Akahoshi, T; Furusyo, N; Hashizume, M; Hayashi, J; Kawanaka, H; Kinjo, N; Maehara, Y; Nagao, Y; Tomikawa, M; Tsutsumi, N1
Antela, A; Bárcena, R; Blázquez, J; del Campo, S; Gil-Grande, L; Moreno, A; Moreno, J; Moreno, L; Moreno, S; Perez-Elías, MJ; Quereda, C; Sánchez, J1
Bárcena, R; Blázquez, J; Foruny, JR; Gil-Grande, L; Moreno, A; Moreno, J; Moreno, S; Muriel, A; Pérez-Elías, MJ; Quereda, C; Rodriguez-Sagrado, MA; Sánchez, J1

Other Studies

6 other study(ies) available for ribavirin and Anemia, Splenic

ArticleYear
Simultaneous splenectomy during liver transplantation augments anti-viral therapy in patients infected with hepatitis C virus.
    American journal of surgery, 2015, Volume: 209, Issue:1

    Topics: Adult; Antiviral Agents; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Hypersplenism; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Splenectomy; Treatment Outcome

2015
Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Female; Genotype; Hepatitis C, Chronic; Humans; Hypersplenism; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Oligopeptides; Platelet Count; Polyethylene Glycols; Pyrophosphatases; Ribavirin; Thrombocytopenia; Treatment Outcome

2015
Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.
    Surgical endoscopy, 2010, Volume: 24, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Female; Genotype; Hepatitis C, Chronic; Humans; Hypersplenism; Interferon alpha-2; Interferon-alpha; Laparoscopy; Length of Stay; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Splenectomy; Tomography, X-Ray Computed; Treatment Outcome; Viral Load

2010
Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Hand-Assisted Laparoscopy; Hepatitis C; Humans; Hypersplenism; Interferon alpha-2; Interferon-alpha; Japan; Laparoscopy; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Splenectomy; Thrombocytopenia; Time Factors; Treatment Outcome

2012
Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin.
    Antiviral therapy, 2004, Volume: 9, Issue:6

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Embolization, Therapeutic; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Hypersplenism; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2004
Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.
    European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:11

    Topics: Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Female; Hepatitis C, Chronic; Humans; Hypersplenism; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Thrombocytopenia; Treatment Outcome

2005